Skip to main content

Advertisement

Table 4 Comparison MDM2 SNP309 allele distribution among oral contraceptive users and non-users between LSIL, HSIL and normal cytology (control)

From: MDM2 polymorphism associated with the development of cervical lesions in women infected with Human papillomavirus and using of oral contraceptives

  Cases Controld
SNP 309 rs2278744 Total SILa LSILb HSILc  
Alleles Yes No Total Yes No Total Yes No Total Yes No Total
T 79 (0.58) 175 (0.63) 254 (0.61) 56 (0.57) 109 (0.68) 165 (0.63) 23 (0.60) 66 (0.58) 89 (0.59) 29 (0.60) 63 (0.66) 92 (0.64)
G 57 (0.42) 101 (0.37) 158 (0.39) 42 (0.43) 53 (0.32) 95 (0.37) 15 (0.40) 48 (0.42) 63 (0.41) 19 (0.40) 33 (0.34) 52 (0.36)
Genotypes             
TT 22 (0.32) 52 (0.38) 74 (0.36) 17 (0.35) 37 (0.46) 54 (0.41) 5 (0.26) 15 (0.27) 20 (0.26) 9 (0.37) 21 (0.44) 30 (0.42)
TG 35 (0.51) 71 (0.51) 106 (0.51) 22 (0.45) 35 (0.43) 57 (0.44) 13 (0.69) 36 (0.63) 49 (0.64) 11 (0.46) 21 (0.44) 32 (0.44)
GG 11 (0.17) 15 (0.11) 26 (0.13) 10 (0.20) 9 (0.11) 19 (0.15) 1 (0.05) 6 (0.10) 7 (0.10) 4 (0.17) 6 (0.12) 10 (0.14)
  1. aSIL: Squamous intraepithelial lesions.
  2. bLSIL: Low-grade squamous intraepithelial lesions.
  3. cHSIL: High-grade squamous intraepithelial lesions.
  4. dControl: Normal cytology.